WHO ICTRP trial
A randomised, double-blind, parallel-group, placebo-controlled phase III study…
EUCTR2008-000622-40-NL · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2008-000622-40-NL |
|---|---|
| Public title | A randomised, double-blind, parallel-group, placebo-controlled phase III study to evaluate the efficacy and safety of desmoteplase in subjects with acute ischemic stroke. - DIAS-3 |
| Scientific title | A randomised, double-blind, parallel-group, placebo-controlled phase III study to evaluate the efficacy and safety of desmoteplase in subjects with acute ischemic stroke. - DIAS-3 |
| Primary sponsor | H. Lundbeck A/S |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): yes Therapeutic use (Phase IV): no |
| Countries | France;Estonia;Hungary;Spain;Austria;Germany;Netherlands |
| Conditions | Acute ischemic stroke within 3 - 9 hours after the onset of symptoms. MedDRA version: 9.1 Level: LLT Classification code 10055221 Term: Ischemic stroke |
| Interventions | Product Name: desmoteplase Product Code: Lu-AE03329 Pharmaceutical Form: Powder for solution for injection INN or Proposed INN: desmoteplase CAS Number: 145137-38-8 Current Sponsor code: Lu-AE03329 Other descriptive name: recombinant… |
| Registration date | Sep 23, 2008 |
| Target size | 400 |
| Secondary IDs | 12402A;N/A |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: